analiza aiqbench
Qiagen is emphasizing that reliable AI agents in drug discovery require a foundation of human-curated knowledge graphs rather than relying solely on generative models prone to hallucination. By integrating Model Context Protocol with decades of expert-verified biomedical data, the company aims to ensure traceable and accurate outputs critical for pharma ROI. This approach highlights the necessity of grounding agentic workflows in trusted provenance before scaling AI applications in high-stakes scientific environments.
Qiagen grounds drug discovery agents in curated knowledge
Qiagen N.V. is betting that drug discovery agents need a trustworthy knowledge foundation as much as capable models. For biopharma companies, that means giving agents information with clear provenance and enough context to support their answers. Knowledge graphs can provide that context layer for AI agents, according to Iman Bhattacharya (pictured), senior global product marketing […] The post Qiagen grounds drug discovery agents in curated knowledge appeared first on SiliconANGLE.
Qiagen N.V. is betting that drug discovery agents need a trustworthy knowledge foundation as much as capable models. For biopharma companies, that means giving agents information with clear provenance and enough context to support their answers. Knowledge graphs can provide that context layer for AI agents, according to Iman Bhattacharya, senior global product…
Extras afișat conform termenilor RSS ai publicației · 53 cuvinte · textul integral și figurile sunt pe site-ul publicației
Subiecte conexe
Manage agents, tools and skills at scale with AWS Agent Registry
AWS · 31 aug. 2026
Announcing the Agentic Catalog Experience in Amazon Quick
AWS · 31 iul. 2026
DeepRoot: A KG-Coordinated Multi-Agent System for Therapeutic Reasoning over Historical Medical Texts
arXiv · 16 iun. 2026
Governance beyond security: knowledge, context & ontology on the lakehouse
Databricks · 3 sept. 2026